Nathalie Leitch
Non-Executive Director
Ms. Nathalie Leitch has over 20 years of experience in the pharmaceuticals industry across multiple segments. She has led commercial management of a branded product line and oversaw the largest pipeline of generic products in the industry. A subject-matter expert in the US generics industry, Ms. Leitch has domain experience in creative product strategies and 505(b)(2) formulations; patent challenges, Hatch-Waxman and settlement options; business development and external-partnering activities. Additionally, she has extensive knowledge of sales, marketing, R&D and manufacturing functions.
Ms. Leitch has steered organizational success in the generic retail and institutional markets. She held senior leadership positions at Apotex, Fresenius Kabi, Teva Pharmaceuticals, Allergan plc, and Actavis (formerly Watson). She has been instrumental in driving company acquisitions and overall consolidation.
Ms. Leitch has a B.Sc. in Human Biology from Trinity College, University of Toronto, Canada, and holds a Finance MBA from Queen’s University, Kingston, Canada.
